funds are drying up .. this is it , page-4

"Why not reflect the facts:
- cash position is satisfactory for another 7.5 quarters at current burn rate"

Sure, but surely weren't these numbers hurriedly put together and based on information QRX had before the unexpected negative announcement? Since then, with added cost pressures to comply with mobile FDA goal posts things may have changed as they often do. Does our new poster Qrx know something we don't?
"- expect to receive revenues in Q4 assuming approval in q3
- CEO has publicly stated they have enough funds to see them through 2013."

Well that's wonderful if do-able.

"A balanced interpretation would be that there might be a CR in the beginning of 2014 to see them through to profitability and accelerate the Extended Release program. Assuming we have a 200m MC by the end of the year (being conservative) a small 10-15% CR would net 20-30m in fresh funds. Seems reasonable to me. The company expects to receive 75m in revenues in the first 18 months post approval so any CR would be small... If they need one."

Personally I am a bit concerned that they will run out of cash by the end of 2013.
For me it matters not a lot. I am simply betting that the flagship MOXDUO gets across the line.
If it doesn't, well I've done my dough and chalk another one up to Madame Hindsight.

But it does depend on the approval and then sales traction.